Nicola Gollan

Real estate investment firm ISPT on Wednesday failed in its challenge to a $10.7 million stamp duty assessment, with a judge finding Victoria's revenue office was entitled to lump two acquisitions together.

Two Deloitte reports commissioned by a Swiss law firm for Credit Suisse are protected by legal professional privilege despite access given to financial regulators investigating the collapse of supply chain financier Greensill. 

Credit Suisse is fighting a bid for access to Deloitte reports commissioned by a Swiss law firm and advice from Linklaters, in litigation against insurers over the collapse of supply chain finance company Greensill Capital. 

A judge has allowed a 50 per cent fee uplift for counsel in an epic fight over lucrative tenements in the Pilbara region, but says the hourly fees of solicitors from the likes of Allens, Clayton Utz and Corrs were already well above market rate.

The Toowoomba Council has asked the High Court to overturn a ruling which found that a 4,000-space car park it operates at the Grand Central shopping centre, where its employees are allowed to park, qualifies as a commercial parking station that is subject to tax. 

Zip Co has reached an agreement to acquire the 'Zip' trade mark from non-bank lender Firstmac, after the High Court rejected its honest concurrent use defence last week.

Zip Co will have to rebrand after losing a challenge to non-bank lender Firstmac’s ‘Zip’ trade mark, with the High Court finding the honest concurrent use is to be judged by the standards of “ordinary, decent people”, not a subjective “Robin Hood” test. 

A court has dismissed a challenge by ISPT to a $20 million tax assessment by the NSW State Revenue's Office over two acquisitions that increased its stake in Fort Street Real Estate Capital Fund.

The operator of a 4,000-space car park at the Grand Central shopping centre in Toowoomba, which is part of a $500 million redevelopment, has lost its fight with the tax office over fringe tax related to employee parking. 

Melbourne-based biopharma Telix has filed a lawsuit against Purdue Research Foundation seeking to invalidate its patent for blockbuster prostate cancer treatment Pluvicto.